This Senate resolution names the first full week in May as "Tardive Dyskinesia Awareness Week." It explains that some people who take antipsychotic medicines can develop tardive dyskinesia (TD), which causes uncontrollable, repetitive movements. The text says antipsychotic prescribing rates are rising and that about 800,000 adults in the United States may have TD, with about 60 percent undiagnosed. It lists groups at higher risk, such as people older than 55, Black individuals, women, people with mood or substance use disorders, intellectual disabilities, or central nervous system injuries, and those with high lifetime antipsychotic exposure. The resolution notes that the American Psychiatric Association recommends routine screening for TD and that the Food and Drug Administration has approved treatments that can help manage TD symptoms. The resolution calls on the Senate to encourage awareness, screening education, and support for people affected by TD.
If you take antipsychotic medicines, care for someone who does, or work in health care, the resolution encourages more attention to TD. It emphasizes early detection, routine screening, and talking with health care providers about symptoms and treatment options. It also supports public awareness activities during the first full week in May.
No publicly available information.
The resolution emphasizes the need for early detection and intervention to improve outcomes for people with mental health conditions and those prescribed antipsychotics. It supports efforts to raise awareness of TD causes and symptoms and the importance of routine TD screening.
No publicly available information.